⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL87733 | 0.79 | — | — | |
| SCHEMBL10472341 | 0.65 | — | — | |
| Ether SCHEMBL3720602 | 0.62 | — | — | |
| SCHEMBL122521 | 0.58 | — | — | |
| SCHEMBL14687187 | 0.55 | — | — | |
| SCHEMBL15015942 | 0.55 | — | — | |
| SCHEMBL570870 | 0.55 | — | — | |
| SCHEMBL12028057 | 0.55 | — | — | |
| SCHEMBL17319696 | 0.50 | — | — | |
| SCHEMBL235610 | 0.48 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12359120-B2 | Organometallic compound, organic light-emitting device including organometallic compound, and apparatus including organometallic compound | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| WO-2024012534-A1 | HETEROCYCLIC FUSED BENZENE RING COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 武汉人福创新药物研发中心有限公司 | 2024-01-18 | — | — | WO | claimed |
| EP-4266445-A1 | SULFUR-BASED BORON TRIFLUORIDE SALT ELECTROLYTE CONTAINING UNSATURATED HETEROCYCLE, PREPARATION METHOD THEREFOR AND USE THEREOF | Beijing WeLion New Energy Technology Co., Ltd (CN) | 2023-10-25 | — | — | EP | claimed |
| WO-2022127194-A1 | SULFUR-BASED BORON TRIFLUORIDE SALT ELECTROLYTE CONTAINING UNSATURATED HETEROCYCLE, PREPARATION METHOD THEREFOR AND USE THEREOF | 北京卫蓝新能源科技有限公司 | 2022-06-23 | — | — | WO | claimed |
| CN-114649576-A | Electrolyte containing bicyclic sulfur-based salt and preparation method and application thereof | 北京卫蓝新能源科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-114649572-A | Sulfur-based boron trifluoride salt-containing electrolyte and preparation method and application thereof | 北京卫蓝新能源科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-114649583-A | Sulfur-based boron trifluoride salt electrolyte containing unsaturated heterocycle and preparation method and application thereof | 北京卫蓝新能源科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-114649585-A | Polycyclic sulfur-based electrolyte and preparation method and application thereof | 北京卫蓝新能源科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-114605443-A | Electrolyte containing unsaturated heterocyclic structure and preparation method and application thereof | 北京卫蓝新能源科技有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-114573610-A | Ternary electrolyte containing unsaturated heterocycle and preparation method and application thereof | 北京卫蓝新能源科技有限公司 | 2022-06-03 | — | — | CN | claimed |
| US-20040220174-A1 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-11-04 | — | — | US | claimed |
| US-20040214808-A1 | Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-28 | — | — | US | claimed |
| US-20040209863-A1 | Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-21 | — | — | US | claimed |
| EP-1465892-A1 | GLYCINAMIDES AS FACTOR XA INHIBITORS | Bristol-Myers Squibb Company (US) | 2004-10-13 | — | — | EP | claimed |
| WO-2004083177-A2 | LINEAR CHAIN SUBSTITUTED MONOCYCLIC AND BICYCLIC DERIVATIVES AS FACTOR XA INHIBITORS | BRYSTOL-MYERS SQUIBB COMPANY (US) | 2004-09-30 | — | — | WO | claimed |
| WO-2004083174-A2 | SULFONYL-AMIDINO CONTAINING AND TETRAHYDROPYRIMIDINO CONTAINING COMPOUNDS AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-09-30 | — | — | WO | claimed |
| US-20030232804-A1 | Glycinamides as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2003-12-18 | — | — | US | claimed |
| US-20030212054-A1 | Substituted amino methyl factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2003-11-13 | — | — | US | claimed |
| US-20030191115-A1 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2003-10-09 | — | — | US | claimed |
| WO-2003048158-A1 | GLYCINAMIDES AS FACTOR XA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-06-12 | — | — | WO | claimed |